Notably, LSD1-KO decreased H3K27Ac occupancy at enhancers/promoters and mRNA expressions of MYC and WNT-β-catenin-target genes, associated with positive enrichment of HALLMARK gene-sets of innate immunity, inflammatory response and apoptosis in AML cells. This evidence concerns the gene KDM1A and acute myeloid leukemia.